β-Phenylethylamine stimulates striatal acetylcholine release through activation of the AMPA glutamatergic pathway

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 9, 2005, Pages 1626-1629

  Ishida, Kota ^a   Murata, Mikio ^a   Kato, Masatoshi ^a   Utsunomiya, Iku ^a   Hoshi, Keiko ^a   Taguchi, Kyoji ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Phenylethylamine; Acetylcholine; Glutamatergic receptor; in vivo microdialysis; Striatum

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PHENETHYLAMINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACETYLCHOLINE; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMATES; INJECTIONS, INTRAPERITONEAL; MALE; MICRODIALYSIS; NEOSTRIATUM; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; STIMULATION, CHEMICAL;

EID: 24944574319     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1626     Document Type: Article

References (36)

1. Durden D. A., Phillips S. R., Boulton A. A., Can. J. Biochem., 51, 995-1002 (1973).
2. Philips S. R., Rozdilsky B., Boulton A. A., Biol. Psychiatry, 13, 51-57 (1978).
3. Reynolds G. P., Sandler M., Hardy J., Bradford H., J. Neurochem., 34, 1123-1125 (1980).
4. Paterson I. A., Juorio A. V., Boulton A. A., J. Neurochem., 55, 1827-1837 (1990).
5. Yang H. Y., Neff N. H., J. Pharmacol. Exp. Ther., 187, 365-371 (1973).
6. Tinklenberg J. R., Gillin J. C., Murphy G. M., Staub R., Wyatt R. J., Am. J. Psychiatry, 135, 576-578 (1978).
7. Dourish C. T., Pharmacol. Biochem. Behav., 22, 159-162 (1985).
8. Barroso N., Rodriguez M., Eur. J. Pharmacol., 297, 195-203 (1996).
9. Geracitano R., Federici M., Prisco S., Bernardi G., Mercuri N. B., Neuropharmacol., 46, 807-814 (2004).
10. Kato M., Ishida K., Chuma T., Abe K., Shigenaga T., Taguchi K., Miyatake T., Eur. J. Pharmacol., 418, 65-71 (2001).
11. Graybiel A. M., Trends Neurol. Sci., 13, 244-254 (1990).
12. Schmidt W. J., J. Neural. Transm., 46, 67-76 (1995).
13. Snell L. D., Johnson K. M., J. Pharmacol. Exp. Ther., 238, 938-946 (1986).
14. Lapper S. R., Bolam J. P., Neuroscience, 51, 533-545 (1992).
15. Spencer H. J., Brain Res., 102, 91-101 (1976).
16. Wilson C. J., Chang J. T., Kitai S. T., Exp. Brain Res., 51, 217-226 (1983).
17. Anderson J. J., Kuo S., Chase T. N., Neurosci. Lett., 176, 264-268 (1994).
18. Consolo S., Baldi G., Giorgi S., Nannini L., Eur. J. Neurosci., 8, 2702-2710 (1996).
19. Ikarashi Y., Yuzurihara M., Takahashi A., Ishimaru H., Shiobara T., Maruyama Y., Brain Res., 795, 215-220 (1998).
20. Knauber J., Kischka U., Roth M., Schmidt W. J., Hennerici M., Fassbender K., J. Neural. Trans., 106, 35-45 (1999).
21. Paxinos G., Watson C., "The Rat Brain in Stereotaxic Coordinates," 2nd ed., Academic Press, London, 1986.
22. Acquas E., Wilson C., Fibiger H. C., J. Pharmacol. Exp. Ther., 281, 360-368 (1997).
23. Kuppenbender K. D., Albers D. S., Iadarola M. J., Landwehrmeter G. B., Standaert D. G., J. Comp. Neurol., 415, 204-217 (1999).
24. Chan W. S., Yeung C. W., Chung E. K., Law W. K., Chan Y. S., Yung K. K., Neurosignals, 12, 302-309 (2003).
25. Giovannini M. G., Camilli F., Mundula A., Bianchi L., Colivicchi A., Pepeu G., Neuroscience, 65, 409-415 (1995).
26. Jin S., Fredholm B. B., Neuropharmacology, 33, 1039-1048 (1994).
27. Jin S., Neuropharmacology, 33, 1503-1510 (1997).
28. Arruda Paes P. C., Magalhaes L., Camillo M. A. P., Rogero J. R., Troncone L. R. P., Neurosci. Res., 49, 289-295 (2004).
29. Hanania T., Johnson K. M., Brain Res., 844, 106-117 (1999).
30. Damsma G., Robertson G. S., Chui-se T., Fibiger H. C., J. Pharmacol. Exp. Ther., 259, 1064-1072 (1991).
31. Hauger R. L., Skolnick P., Paul S. M., Eur. J Pharmacol., 83, 147-148 (1982).
32. Borowsky B., Adham N., Jones K. A., Raddatz R., Artymyshyn R., Ogozalek K. L., Durkin M. M., Lakhlani P. P., Bonini J. A., Pathirana S., Boyle N., Pu X., Kouranova E., Lichtblau H., Ochoa F. Y., Branchek T. A., Gerald C., Proc. Natl. Acad. Sci. U.S.A., 98, 8966-8971 (2001).
33. Bunzow J. R., Sonders M. S., Arttamangkul S., Harrison L. M., Zhang G., Quigley D. I., Darland T., Suchland K. L., Pasumamula S., Kennedy J. L., Olson S. B., Magenis R. E., Amara S. G., Grandy D. K.. Mol. Pharmacol., 60, 1181-1188 (2001).
34. Paterson I. A., Boulton A. A., Brain Res. Bull., 20, 173-177 (1988).
35. Dyck L. E., Yang C. R., Boulton A. A., J. Neurochem. Res., 10, 211-220 (1983).
36. Bailey B. A., Phillips S. R., Boulton A. A., Neurochem. Res., 12, 173-178 (1987).